824 filings
Page 7 of 42
UPLOAD
hq2wff
22 Jan 21
Letter from SEC
12:00am
8-K
rnc170l5dvpi8guiul5
22 Dec 20
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
9:15am
8-K
bgalka5pgx fmr9zt
16 Dec 20
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
4:31pm
8-K/A
762qm6l9r2
3 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:35pm
DEFA14A
bfdtgm9pjcp
25 Nov 20
Additional proxy soliciting materials
7:31am
8-K
t6vmu6xshi pw9b
25 Nov 20
Submission of Matters to a Vote of Security Holders
7:30am
8-K
x7wm8ljat
18 Sep 20
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
rlnjrq
10 Sep 20
Advantages of the CiVax™ Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
7:32am
EFFECT
h1k4luxqjv6a tm2olu
31 Aug 20
Notice of effectiveness
12:15am
424B5
bnk56qr1
28 Aug 20
Prospectus supplement for primary offering
4:48pm
8-K
osfk4dw fpk
28 Aug 20
Entry into a Material Definitive Agreement
4:37pm
CORRESP
aj42 b6ag61yc
26 Aug 20
Correspondence with SEC
12:00am
DEFA14A
xm5 qgob6ljz
13 Aug 20
Additional proxy soliciting materials
4:30pm
DEFA14A
r25m05 6vx
7 Aug 20
Additional proxy soliciting materials
4:37pm